09:39 AM EST - Reunion Neuroscience Inc. : Reported fiscal results for the fourth quarter and year ended March 31, 2023. The Company recognized a net loss from discontinued operations of $10.4 million for the 12-month period ended March 31, 2023. No such loss was incurred during the three-month period ended March 31, 2023. This compares to a $8.2 and $36.9 million loss for the three- and 12-month periods ended March 31, 2022. Discontinued operations are attributable to the spinout of Clinic Operations completed on August 11, 2022. Reunion Neuroscience Inc.
shares T.REUN are trading unchanged at $1.45.